John Gnann to Viral Envelope Proteins
This is a "connection" page, showing publications John Gnann has written about Viral Envelope Proteins.
Connection Strength
0.118
-
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis. Antiviral Res. 2004 Nov; 64(2):103-11.
Score: 0.060
-
T cell recognition of HIV synthetic peptides in a natural infection. J Immunol. 1989 Feb 15; 142(4):1166-76.
Score: 0.020
-
Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections. Methods Enzymol. 1989; 178:693-714.
Score: 0.020
-
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science. 1987 Sep 11; 237(4820):1346-9.
Score: 0.018